Thomas J. Cancro's most recent trade in Tabula Rasa HealthCare Inc was a trade of 37,037 Common Stock done . Disclosure was reported to the exchange on April 19, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tabula Rasa HealthCare Inc | Thomas J. Cancro | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2023 | 37,037 | 248,537 (1%) | 0% | 0 | Common Stock | |
| Tabula Rasa HealthCare Inc | Thomas J. Cancro | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 4.34 per share. | 12 Dec 2022 | 11,500 | 211,500 (0%) | 0% | 4.3 | 49,910 | Common Stock |
| Tabula Rasa HealthCare Inc | Thomas J. Cancro | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 200,000 | 200,000 (0%) | 0% | 0 | Common Stock | |
| DZS Inc | Thomas J. Cancro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| DZS Inc | Thomas J. Cancro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |